Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03884647

NCT03884647
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are between 50 and 75 years old (inclusive) and are either male or female.
  • You have at least one risk factor for stroke or dementia — this includes things like a previous stroke or mini-stroke (TIA), high blood pressure, high cholesterol, diabetes, an irregular heartbeat (atrial fibrillation), other heart conditions (such as a past heart attack or valve problems), current or past heavy smoking (more than 20 cigarettes a day), being overweight or obese (BMI over 25), a family history of dementia, being aged 65 or older, or having sleep problems.
  • You or a family member have noticed memory or thinking problems, or there is some objective evidence of cognitive (thinking/memory) difficulties.
  • You are willing to take part in all parts of the study.

Who may not be able to join:

  • You have a degenerative brain or nervous system disease (confirm with trial site).
  • You have a neurological condition present from birth or early development, such as cerebral palsy, brain damage from lack of oxygen, or autism spectrum disorder.
  • You have Multiple Sclerosis (MS).
  • You have a major mental health condition such as PTSD, bipolar disorder, schizophrenia, or a substance use disorder.
  • You have a chronic (long-term) pain condition.
  • You have a history of a brain tumor, brain surgery, or radiation treatment to the brain.
  • You have ever had an epileptic seizure.
  • You have any metal implants in your brain, such as a shunt, pacemaker, clips, coils, bullet fragments, or cochlear implants.
  • You have any implanted device controlled by body signals, or any magnetic metal implanted in your head or within 30 cm of the treatment area.
  • You have any reason you cannot have an MRI scan.
  • You have had a significant head injury in the past, such as losing consciousness or being diagnosed with a brain bruise (contusion) after a head injury.
  • You are currently taking opioid painkillers, antipsychotic medications, or anti-epileptic medications.
  • You have taken sleeping pills, antidepressants (SSRIs), or anti-anxiety medications within 12 hours before the study evaluation.
  • You currently use recreational drugs.
  • You are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
QuantalX Neuroscience
Registry
clinicaltrials_gov
Start date
1 April 2020
Est. completion
6 May 2022

Where this trial is recruiting

🇮🇱 Israel 🇺🇸 United States

Primary endpoints

Establishing DELPhI's norms of population 50-75 years old at risk for stroke and dementia; Establish DELPhI's safety in subjects 50-75 at risk for stroke and dementia.; DELPHI's reliability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov